NEW YORK, June 23 (GenomeWeb News) - Cepheid has expanded its license to Applera's core PCR patents to include real-time PCR for applications in thermal cyclers, the companies said today.
Cepheid has obtained a non-exclusive global license to make, use, and sell its SmartCycler and GeneXpert brand thermal cyclers, as well as other Cepheid thermal cyclers, using Applera's real-time PCR technology.
Additionally, with a payment of $11.5 million over a two-year period, Cepheid expands its rights under its existing thermal-cycler supplier agreement with Applera to include human diagnostics but not HIV and Hepatitis C applications.
The licensing deal was announced as Applera's Applied Biosystems group obtained injunctions to halt the manufacture and sale of RT-PCR thermal cyclers by a group of companies. For details, click here.